Article

Facoemulsificação versus extração extracapsular manual do cristalino: análise de custos

Arquivos Brasileiros de Oftalmologia 01/2004; DOI: 10.1590/S0004-27492004000300021
Source: DOAJ

ABSTRACT OBJETIVO: Avaliar aspectos clínicos e econômicos da cirurgia de catarata pela técnica de facoemulsificação, quando comparada à técnica de extração extracapsular do cristalino no Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. MÉTODOS: Estudo prospectivo em que foram selecionados consecutivamente 162 pacientes, portadores de catarata senil, atendidos em projetos comunitários para identificação e posterior tratamento da catarata (Projetos-Catarata), que atenderam aos critérios de inclusão para o estudo. Esses projetos foram realizados pelo Hospital das Clínicas, entre outubro de 2001 e junho de 2002. Os pacientes selecionados foram randomizados para comporem dois grupos, que seriam submetidos à cirurgia de catarata pela técnica de facoemulsificação e de extração extracapsular. RESULTADOS: Nas condições do estudo, a técnica de facoemulsificação permitiu o uso de anestesia tópica, reduziu o número de retornos e o tempo de duração do período pós-operatório. A utilização da facoemulsificação tornou a cirurgia mais rápida, otimizou o centro cirúrgico e apresentou vantagens econômicas para o hospital. CONCLUSÃO: No tocante às condições do Hospital das Clínicas, os custos totais da cirurgia de catarata mediante a técnica de facoemulsificação são maiores do que os custos com a técnica de extração extracapsular; e a remuneração efetuada pelo Sistema Único de Saúde para a cirurgia por facoemulsificação confere maiores vantagens econômicas ao hospital do que a cirurgia por extração extracapsular.

0 Bookmarks
 · 
283 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: PURPOSE: To compare the costs of cataract surgery for a public hospital, the government and the society between the techniques of phacoemulsification (PHACO) and extracapsular cataract extraction (EECP). METHODS: A review based on several clinical studies between 2002 and 2010 at the Ambulatorial Surgical Center of the University of São Paulo. RESULTS: The estimated expenses associated with medical supplies used for surgery were R$ 468.92 and R$ 259.96 in the PHACO and EECP groups respectivelly. The hospital expenditures in the postoperative follow-up was approximately R$ 16.40 (42%) lower in the PHACO. Regarding the estimated spending for Social Security, the EECP group cost an average, US$ 44.58 per patient more than the PHACO group.
    Revista brasileira de oftalmologia 04/2012; 71(2):115-124. · 0.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: PURPOSE: The objective of this study was to compare the estimated cost of clinical and surgical treatment for basl cell carcinoma of the eyelid. METHODS: This was a pilot study of 12 patients with basal cell carcinoma receiving treatment with 5% imiquimod cream at the ocular plastic surgery center, medical school University of São Paulo (HC-FMUSP, Brazil). The cost of clinical treatment was estimated based on the time of treatment and amount of medication consumed by patients in the home setting. The cost of surgical treatment was estimated by ophthalmologists with experience in reconstructive plastic surgery based on analysis of images of the same patients. Surgeons responded to a questionnaire with four questions about surgical technique, surgical materials required, estimated duration of surgery and type of anesthesia. RESULTS: Immunotherapy lasted from 8 to 12 weeks.All patients reported each coldstored sachet with 5% imiquimod cream lasted 3 days.According to the institution, a box with 12 sachets costs BRL 480.00. Patients required 1.58-3.11 boxes for complete treatment, corresponding to a total cost of BRL 758.401,492.80. Based on image analysis, surgeons evaluated surgery would require 1-3 hours. The estimated cost of surgery room and staff was BRL 263.00, to which the cost of supplies was added. Thus, the total cost of surgical treatment was BRL 272.61-864.82. On the average, immunotherapy was 57,64% more costly than surgical treatment. CONCLUSIONS: Malignant eyelid tumors are a common finding in clinical ophthalmology. Surgery is still the treatment of choice at our institution, but immunotherapy with 5% imiquimod cream may be indicated for patients with multiple lesions or high surgical risk and for patients declining surgery for reasons of fear or esthetic concerns.The ability to estimate costs related to the treatment of malignant eyelid tumors is an important aid in the financial planning of health care institutions. Further studies should evaluate the possibility of institutions equating the cost of immunotherapy and surgical treatment by acquiring similar but less expensive medications.
    Revista brasileira de oftalmologia 06/2012; 71(3):180-183. · 0.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To study the quality of life, treatment outcomes, and satisfaction in patients who have undergone cataract surgery Methods: This comparative case series study was conducted at the Ophthalmology Service of the Bettina Ferro de Souza University Hospital, Belém, Pará, Brazil. Totally, 60 patients with cataract were included; 50% underwent conventional extracapsular cataract extraction (ECEE) and 50% underwent cataract extraction by phacoemulsification (PHACO). Patients were interviewed using the Visual Function 14 (VF-14) questionnaire to determine the quality of life before and 30 days after surgery. The results of ophthalmological examination were recorded in the patients' files and were available throughout this study. One-way ANOVA, Tukey's post-hoc comparison, and the sign test were used for statistical analyses.
    Arquivos brasileiros de oftalmologia. 01/2014; 77(1):12-6.

Full-text

View
3 Downloads
Available from